209 related articles for article (PubMed ID: 31699957)
1. The increased gray matter volumes of precentral gyri in Parkinson's disease patients with diphasic dyskinesia.
Zhi Y; Wang M; Yuan YS; Shen YT; Ma KW; Gan CT; Si QQ; Wang LN; Cao SW; Zhang KZ
Aging (Albany NY); 2019 Nov; 11(21):9661-9671. PubMed ID: 31699957
[TBL] [Abstract][Full Text] [Related]
2. Patterns of Grey Matter Atrophy at Different Stages of Parkinson's and Alzheimer's Diseases and Relation to Cognition.
Kunst J; Marecek R; Klobusiakova P; Balazova Z; Anderkova L; Nemcova-Elfmarkova N; Rektorova I
Brain Topogr; 2019 Jan; 32(1):142-160. PubMed ID: 30206799
[TBL] [Abstract][Full Text] [Related]
3. Prefrontal thickening in PD with levodopa-induced dyskinesias: new evidence from cortical thickness measurement.
Cerasa A; Morelli M; Augimeri A; Salsone M; Novellino F; Gioia MC; Arabia G; Quattrone A
Parkinsonism Relat Disord; 2013 Jan; 19(1):123-5. PubMed ID: 22742954
[TBL] [Abstract][Full Text] [Related]
4. Age at onset influences neurodegenerative processes underlying PD with levodopa-induced dyskinesias.
Cerasa A; Salsone M; Morelli M; Pugliese P; Arabia G; Gioia CM; Novellino F; Quattrone A
Parkinsonism Relat Disord; 2013 Oct; 19(10):883-8. PubMed ID: 23769805
[TBL] [Abstract][Full Text] [Related]
5. Reduced gray matter volume is correlated with frontal cognitive and behavioral impairments in Parkinson's disease.
Terada T; Miyata J; Obi T; Kubota M; Yoshizumi M; Murai T
J Neurol Sci; 2018 Jul; 390():231-238. PubMed ID: 29801896
[TBL] [Abstract][Full Text] [Related]
6. Increased prefrontal volume in PD with levodopa-induced dyskinesias: a voxel-based morphometry study.
Cerasa A; Messina D; Pugliese P; Morelli M; Lanza P; Salsone M; Novellino F; Nicoletti G; Arabia G; Quattrone A
Mov Disord; 2011 Apr; 26(5):807-12. PubMed ID: 21384430
[TBL] [Abstract][Full Text] [Related]
7. Frontal and subcortical contribution to visual hallucinations in dementia with Lewy bodies and Parkinson's disease.
Pezzoli S; Cagnin A; Antonini A; Venneri A
Postgrad Med; 2019 Sep; 131(7):509-522. PubMed ID: 31422718
[No Abstract] [Full Text] [Related]
8. Cerebellar connectivity in Parkinson's disease with levodopa-induced dyskinesia.
Yoo HS; Choi YH; Chung SJ; Lee YH; Ye BS; Sohn YH; Lee JM; Lee PH
Ann Clin Transl Neurol; 2019 Nov; 6(11):2251-2260. PubMed ID: 31643140
[TBL] [Abstract][Full Text] [Related]
9. Brain MRI morphometric analysis in Parkinson's disease patients with sleep disturbances.
Radziunas A; Deltuva VP; Tamasauskas A; Gleizniene R; Pranckeviciene A; Petrikonis K; Bunevicius A
BMC Neurol; 2018 Jun; 18(1):88. PubMed ID: 29925331
[TBL] [Abstract][Full Text] [Related]
10. Basal ganglia atrophy-associated causal structural network degeneration in Parkinson's disease.
Li R; Zou T; Wang X; Wang H; Hu X; Xie F; Meng L; Chen H
Hum Brain Mapp; 2022 Feb; 43(3):1145-1156. PubMed ID: 34792836
[TBL] [Abstract][Full Text] [Related]
11. Microstructural and functional alterations of the ventral pallidum are associated with levodopa-induced dyskinesia in Parkinson's disease.
Gan Y; Su D; Zhang Z; Zhang Z; Yan R; Liu Z; Wang Z; Zhou J; Lam JST; Wu T; Jing J; Feng T
Eur J Neurol; 2024 Feb; 31(2):e16147. PubMed ID: 37975786
[TBL] [Abstract][Full Text] [Related]
12. Prefrontal alterations in Parkinson's disease with levodopa-induced dyskinesia during fMRI motor task.
Cerasa A; Pugliese P; Messina D; Morelli M; Gioia MC; Salsone M; Novellino F; Nicoletti G; Arabia G; Quattrone A
Mov Disord; 2012 Mar; 27(3):364-71. PubMed ID: 22076870
[TBL] [Abstract][Full Text] [Related]
13. White matter alterations in Parkinson's disease with levodopa-induced dyskinesia.
Ogawa T; Hatano T; Kamagata K; Andica C; Takeshige-Amano H; Uchida W; Saito Y; Shimo Y; Oyama G; Umemura A; Iwamuro H; Ito M; Hori M; Aoki S; Hattori N
Parkinsonism Relat Disord; 2021 Sep; 90():8-14. PubMed ID: 34325387
[TBL] [Abstract][Full Text] [Related]
14. Voxelwise meta-analysis of gray matter anomalies in Parkinson variant of multiple system atrophy and Parkinson's disease using anatomic likelihood estimation.
Shao N; Yang J; Shang H
Neurosci Lett; 2015 Feb; 587():79-86. PubMed ID: 25484255
[TBL] [Abstract][Full Text] [Related]
15. Different patterns of gray matter density in early- and middle-late-onset Parkinson's disease: a voxel-based morphometry study.
Xuan M; Guan X; Huang P; Shen Z; Gu Q; Yu X; Xu X; Luo W; Zhang M
Brain Imaging Behav; 2019 Feb; 13(1):172-179. PubMed ID: 28667375
[TBL] [Abstract][Full Text] [Related]
16. Gray matter correlates of dopaminergic degeneration in Parkinson's disease: A hybrid PET/MR study using (18) F-FP-CIT.
Choi H; Cheon GJ; Kim HJ; Choi SH; Kim YI; Kang KW; Chung JK; Kim EE; Lee DS
Hum Brain Mapp; 2016 May; 37(5):1710-21. PubMed ID: 26846350
[TBL] [Abstract][Full Text] [Related]
17. Functional and structural changes in gray matter of parkinson's disease patients with mild cognitive impairment.
Chen B; Wang S; Sun W; Shang X; Liu H; Liu G; Gao J; Fan G
Eur J Radiol; 2017 Aug; 93():16-23. PubMed ID: 28668411
[TBL] [Abstract][Full Text] [Related]
18. Altered functional connectivity of cerebellar dentate nucleus in peak-dose dyskinesia in Parkinson's disease.
Zhang H; Wang L; Gan C; Cao X; Ji M; Sun H; Yuan Y; Zhang K
Front Aging Neurosci; 2022; 14():943179. PubMed ID: 36034152
[TBL] [Abstract][Full Text] [Related]
19. Effect of bilateral subthalamic deep brain stimulation on diphasic dyskinesia.
Kim HJ; Lee JY; Kim JY; Kim DG; Paek SH; Jeon BS
Clin Neurol Neurosurg; 2008 Apr; 110(4):328-32. PubMed ID: 18164541
[TBL] [Abstract][Full Text] [Related]
20. Gray and White Matter Contributions to Cognitive Frontostriatal Deficits in Non-Demented Parkinson's Disease.
Price CC; Tanner J; Nguyen PT; Schwab NA; Mitchell S; Slonena E; Brumback B; Okun MS; Mareci TH; Bowers D
PLoS One; 2016; 11(1):e0147332. PubMed ID: 26784744
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
